A comparison of Glucagon-like peptide-1 receptor agonists on weight change, side effects, and quality of life in Kuwait
This study highlights the varying effectiveness and tolerability of GLP-1 RAs for weight loss in Kuwait, with Tirzepatide showing the highest satisfaction and weight loss. Liraglutide users experienced more anxiety and medication switches, while Semaglutide users had moderate outcomes. Despite their benefits, GLP-1 RAs face challenges in long-term adherence due to side effects and cost.
Authors
- N. Ben Achour (ORCID: https://orcid.org/0000-0001-7776-2140)
- Wed S Alotaibi
- Saad Al‐Ali
- Arif Al‐Mulla
- Karen Ashodian
- Hessa Mutlaq
Institutions
- Kuwait University (KW)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2025-05-19
- DOI
- https://doi.org/10.3389/fnut.2025.1590379
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Kuwait University